Fig. 1
From: DCYTB is a predictor of outcome in breast cancer that functions via iron-independent mechanisms
High DCYTB expression is associated with increased recurrence-free survival in breast cancer. Kaplan-Meier analysis of breast cancer patient microarray data subsetted into high and low DCYTB expression groups (above and below the mean). a Cohort #1 distant metastasis-free survival (p = 1.6e-11, n = 741, log-rank test); b cohort #2 relapse-free survival (both local and distant) (p = 1.2e-05, n = 869, log-rank test); c subgroup of cohort #2 (GSE2034) bone-specific relapse-free survival (p = 0.01, n = 272, log-rank test). DCYTB duodenal cytochrome b